Submissions

Online Submissions

Already have a Username/Password for J. Serb. Chem. Soc.?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

Due to limitations of text formatting in html version of Instructions for authors and Artwork Instructions, please use the PDF version of the Instructions (regrding the formatting of text, labels, equations and Designation of the physical quantities and units).

Instructions for Authors - pdf
Artwork Instructions - pdf
Check List - pdf
Common_mistakes -pdf


DOWNLOAD JSCS TEMPLATE(Right click - save as... option) 

GENERAL
The Journal of the Serbian Chemical Society (the Journal in further text) is an international journal publishing papers from all fields of chemistry and related disciplines. Twelve issues are published annually.

The Editorial Board expects the editors, reviewers and authors to respect the well-known standard of professional ethics.

TYPES OF CONTRIBUTIONS

Original scientific papers

(about 20 typewritten pages) report original research which must not have been previously published.

Short communications

(about 10 pages) report unpublished preliminary results of sufficient importance to merit rapid publication.

Notes

(about 8 pages) report unpublished results of short, but complete, original research

Authors’ reviews

(about 50 pages) present an overview of the author’s current research with comparison to data of other scientists working in the field

Reviews*

(about 50 pages) present a concise and critical survey of a specific research area. Generally, these are prepared at the invitation of the Editor

Surveys

(about 25 pages) communicate a short review of a specific re­search area.

Book and Web site reviews

(1 ‑ 2 pages)

Extended abstracts

(about 4 pages) of Lectures given at meetings of the Serbian Chemical Society Divisions

Letters to the Editor

report miscellaneous topics directed directly to the Editor

*Generally, Authors’ reviews, Reviews and Surveys are prepared at the invitation of the Editor.

SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted using the OnLine Submission Form. The manuscript must be uploaded as a Word.doc or .rtf file, with tables and figures (including the corresponding captions - above Tables and below Figures), placed within the text to follow the paragraph in which they were mentioned for the first time. Illustrations (Figs, schemes, photos…) in TIF or EPS format (JPG format is acceptable for colour and greyscale photos, only), must be additionally uploaded (Online Submissions Step 4) as a separate files or one archived (.zip, .rar or .arj) file. Figures and/or Schemes should be prepared according to the Artwork Instructions! Maximum single file size is 32MB

Manuscripts must be accompanied by a cover letter (strictly uploaded in Online Submission Step 4 for Supplementary Files) in which the type of the submitted manuscript and a warranty as given below are given. The Author(s) has(have) to warranty that the manuscript submitted to the Journal for review is original, has been written by the stated author(s) and has not been published elsewhere; is currently not being considered for publication by any other journal and will not be submitted for such a review while under review by the Journal; the manuscript contains no libellous or other unlawful statements and does not contain any materials that violate any personal or proprietary rights of any other person or entity. All manuscripts will be acknowledged on receipt (by e-mail).

For any difficulties and questions related to OnLine Submission Form, please refer to Journal Help Section. Also, in each of 5 steps of OnLine Submission Form there are brief instructions of actions that need completion. If difficulties still persists, please contact JSCS Editorial Office at JSCS@shd.org.rs

A MANUSCRIPT NOT PREPARED ACCORDING TO THESE INTRUCTIONS WILL BE RETURNED 
FOR RESUBMITION WITHOUT BEING ASSIGNED A REFERENCE NUMBER.

Conflict-of-Interest Statement*: Public trust in the peer review process and the credibility of published articles depend in part on how well a conflict of interest is handled during writing, peer review, and editorial decision making. A conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for a conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

Informed Consent Statement*: Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.  Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.  The requirement for informed consent should be included in the journal's instructions for authors. When informed consent has been obtained it should be indicated in the published article.

Human and Animal Rights Statement*: When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.       

* International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") -- February 2006

PROCEDURE
All contributions will be peer reviewed and only those deemed worthy and suitable will be accepted for publication. The Editor has the final decision. To facilitate the reviewing process, authors are encouraged to suggest up to three persons competent to review their manuscript. Such suggestions will be taken into consideration but not always accepted. If authors would prefer a specific person not be a reviewer, this should be announced. The Cover Letter must be accompanied by these suggestions.

Manuscripts requiring revision should be returned according to the requirement of the Editor, within 60 days upon reception of the reviewing comments by e-mail, or the manuscript will be considered as having been withdrawn. Later, the manuscript would have to be resubmitted.

The Journal maintains its policy and takes the liberty of correcting the English as well as false content of manuscripts provisionally accepted for publication in the first stage of reviewing process. In this second stage of manuscript preparation by JSCS Editorial Office, the author(s) may be required to supply some additional clarifications and corrections. This procedure will be executed during copyediting actions, with a demand to author(s) to perform corrections of unclear parts before the manuscript would be published OnLine as finally accepted manuscript (OnLine First Section of the JSCS website). Please note that the manuscript can receive the status of final rejection if the author’s corrections would not be satisfactory.

When finally accepted manuscript is ready for printing, the corresponding author will receive a request for proof reading, which should be performed within 2 days. Failure to do so will be taken as the authors are in agreement with any alteration which may have occurred during the preparation of the manuscript for printing.
Accepted manuscripts of active members of the Serbian Chemical Society (all authors) have publishing priority.

MANUSCRIPT PRESENTATION
Manuscripts should be typed in English (either standard British or American English, but consistent throughout) with 1.5 spacing (12 points Times New Roman; Greek letters in the character font Symbol) in A4 format leaving 2.5 cm for margins. For Regional specific, non-standard characters that may appear in the text, save documents with Embed fonts Word option: Save as -> (Tools) -> Save Options… -> Embed fonts in the text.

The authors are requested to seek the assistance of competent English language expert, if necessary, to ensure their English is of a reasonable standard. The Serbian Chemical Society can provide this service in advance of submission of the manuscript. If this service is required, please contact the office of the Society by e-mail (jscs-info@shd.org.rs).

Tables, figures and/or schemes must be embedded in the main text of the manuscript and should follow the paragraph in which they are mentioned for the first time. Tables must be prepared with the aid of the WORD table function, without vertical lines. The minimum size of the font in the tables should be 10 pt. Table columns must not be formatted using multiple spaces. Table rows must not be formatted using any returns (enter key; return key) and are limited to 12 cm length. Tables should not be incorporated as graphical objects. Footnotes to tables should follow them and are to be indicated consequently (in a single line) in superscript letters and separated by semi-column.  Table caption must be placed above corresponding Table, while Captions of the Illustrations (Figs. Schemes...) must follow the corresponing item. The captions, either for Tables or Illustrations, should make the items comprehensible without reading of the main text (but clearly referenced in), must follow numerical order (Roman for Tables, Arabic for Illustrations), and should not be provided on separate sheats or as separate files.

High resolution Illustrations (named as Fig. 1, Fig. 2… and/or Scheme 1, Scheme 2…) in TIF or EPS format (JPG format is acceptable for colour and greyscale photos, only) must be additionally uploaded (Online Submissions Step 4) as a separate files or one archived (.zip, .rar or .arj) file.

Illustrations should be prepared according to the ARTWORK INSTRUCTIONS!

All pages of the manuscript must be numbered continuously.

IUPAC recommendations for the naming of compounds should be followed. SI units, or other permissible units, should be employed. The designation of physical quantities must be in italic throughout the text (including figures, tables and equations), whereas the units and indexes (except for indexes having the meaning of physical quantities) are in upright letters. They should be in Times New Roman font. In graphs and tables, a slash should be used to separate the designation of a physical quantity from the unit (example: p / kPa, j / mA cm-2T0 / K, t / h, ln (j / mA cm-2)…). Designations such as: p (kPa), t [min]…, are not acceptable. However, if the full name of a physical quantity is unavoidable, it should be given in upright letters and separated from the unit by a comma (example: Pressure, kPa; Temperature, K; Current density, mA cm-1…).. Please do not use the axes of graphs for additional explanations; these should be mentioned in the figure captions and/or the manuscript (example: “pressure at the inlet of the system, kPa” should be avoided). The axis name should follow the direction of the axis (the name of y‑axis should be rotated by 90°). Top and right axes should be avoided in diagrams, unless they are absolutely necessary.

Latin words, as well as the names of species, should be in italic, as for example: i.e., e.g., in vivo, ibid, Calendula officinalis L., etc. The branching of organic compound should also be indicated in italic, for example, n-butanol, tert-butanol, etc.

Decimal numbers must have decimal points and not commas in the text (except in the Serbian abstract), tables and axis labels in graphical presentations of results. Thousands are separated, if at all, by a comma and not a point.

 

ARTICLE STRUCTURE

  • TITLE PAGE
  • MAIN TEXT - including Tables and Illustrations with corresponding captions 
  • SUPPLEMENTARY MATERIAL (optional)

Title page

Title in bold letters, should be clear and concise, preferably 12 words or less. The use of non-standard abbreviations, symbols and formulae is discouraged.

AUTHORS’ NAMES in capital letters with the full first name, initials of further names separated by a space and surname. Commas should separate the author’s names except for the last two names when ‘and’ is to be used. In multi-affiliation manuscripts, the author’s affiliation should be indicated by an Arabic number placed in superscript after the name and before the affiliation. Use * to denote the corresponding author(s).

Affiliations should be written in italic. The e-mail address of the corresponding author should be given after the affiliation(s).

Abstract: A one-paragraph abstract written of 150 – 200 words in an impersonal form indicating the aims of the work, the main results and conclusions should be given and clearly set off from the text. Domestic authors should also submit, on a separate page, an Abstract - Izvod, the author’s name(s) and affiliation(s) in Serbian (Cyrillic letters). (Домаћи аутори морају доставити Извод (укључујући имена аутора и афилијацију) на српском језику, исписане ћирилицом, иза Захвалнице, а пре списка референци.) For authors outside Serbia, the Editorial Board will provide a Serbian translation of their English abstract.

Keywords: Up to 6 keywords should be given. Do not use words appearing in the manuscript title

RUNNING TITLE: A one line (maximum five words) short title in capital letters should be provided.

Main text
The main text should have the form:
INTRODUCTION,
EXPERIMENTAL (RESULTS AND DISCUSSION)
RESULTS AND DISCUSSION (EXPERIMENTAL)
CONCLUSIONS
NOMENCLATURE (optional)
Acknowledgements: If any.
REFERENCES (Citation of recent papers published in chemistry journals that highlight the significance of work to the general readership is encouraged.)

The sections should be arranged in a sequence generally accepted for publication in the respective fields. They subtitles should be in capital letters, centred and NOT numbered.

The INTRODUCTION should include the aim of the research and a concise description of background information and related studies directly connected to the paper.

The EXPERIMENTAL section should give the purity and source of all employed materials, as well as details of the instruments used. The employed methods should be described in sufficient detail to enable experienced persons to repeat them. Standard procedures should be referenced and only modifications described in detail.

On no account should results be included in the experimental section.

Chemistry
Detailed informations about instruments and general experimental techniques should be given in all necessary details. If special treatment for solvents or chemical purification were applied that must be emphasized.
Example: Melting points were determined on a Boetius PMHK or a Mel-Temp apparatus and were not corrected. Optical rotations were measured on a Rudolph Research Analytical automatic polarimeter, Autopol IV in dichloromethane (DCM) or methanol (MeOH) as solvent. IR spectra were recorded on a Perkin-Elmer spectrophotometer FT-IR 1725X. 1H and 13C NMR spectra were recorded on a Varian Gemini-200 spectrometer (at 200 and 50 MHz, respectively), and on a Bruker Ultrashield Advance III spectrometer (at 500 and 125 MHz, respectively) employing indicated solvents (vide infra) using TMS as the internal standard. Chemical shifts are expressed in ppm (δ / ppm) values and coupling constants in Hz (J / Hz). ESI-MS spectra were recorded on Agilent Technologies 6210 Time-Of-Flight LC-MS instrument in positive ion mode with CH3CN/H2O 1/1 with 0.2 % HCOOH as the carrying solvent solution. Samples were dissolved in CH3CN or MeOH HPLC grade purity). The selected values were as follows: capillary voltage = 4 kV, gas temperature = 350 °C, drying gas flow 12 L min−1, nebulizer pressure = 310 kPa, fragmentator voltage = 70 V.The elemental analysis was performed on the Vario EL III- C,H,N,S/O Elemental Analyzer (Elementar Analysensysteme GmbH, Hanau-Germany). Thin-layer chromatography (TLC) was performed on precoated Merck silica gel 60 F254 and RP-18 F254 plates. Column chromatography was performed on Lobar LichroPrep Si 60 (40-63 µm), RP-18 (40-63 µm) columns coupled to a Waters RI 401 detector, and on Biotage SP1 system with UV detector and FLASH 12+, FLASH 25+ or FLASH 40+ columns pre packed with KP-SIL [40-63 µm, pore diameter 6 nm (60 Å)], KP-C18-HS (40-63 µm, pore diameter 9 nm (90 Å) or KP-NH [40-63 µm, pore diameter 10 nm (100 Å)] as adsorbent. Compounds were analyzed for purity (HPLC) using a Waters 1525 HPLC dual pump system equipped with an Alltech, Select degasser system, and dual λ 2487 UV-VIS detector. For data processing, Empower software was used (methods A and B). Methods C and D: Agylent Тechnologies 1260 Liquid Chromatograph equipped with Quat Pump (G1311B), Injector (G1329B) 1260 ALS, TCC 1260 (G1316A) and Detector 1260 DAD VL+ (G1315C). For data processing, LC OpenLab CDS ChemStation software was used. For details, see Supporting Information.

1. Synthesis experiments
Each paragraph describing a synthesis experiment should begin with the name of the product and any structure number assigned to the compound in the Results and Discussions section. Thereafter, the compound should be identified by its structure number. Use of standard abbreviations or unambiguous molecular formulas for reagents and solvents, and of structure numbers rather than chemical names to identify starting materials and intermediates, is encouraged.
When a new or improved synthetic method is described, the yields reported in key experimental examples, and yields used for comparison with existing methods, should represent amounts of isolated and purified products, rather than chromate­gra­phically or spectroscopically determined yields. Reactant quantities should be reported in weight and molar units and for product yields should be reported in weight units; percentage yields should only be reported for materials of demonstrated purity. When chromatography is used for product purification, both the support and solvent should be identified.

2. Microwave experiments
Reports of syntheses conducted in microwave reactors must clearly indicate whether sealed or open reaction vessels were used and must document the manufacturer and model of the reactor, the method of monitoring the reaction mixture temperature, and the temperature-time profile. Reporting a wattage rating or power setting is not an acceptable alternative to providing temperature data. Manuscripts describing work done with domestic (kitchen) microwave ovens will not be accepted except for studies where the unit is used for heating reaction mixtures at atmospheric pressure.

3. Compound characterization

The Journal upholds a high standard for compound characterization to ensure that substances being added to the chemical literature have been correctly identified and can be synthesized in known yield and purity by the reported preparation and isolation methods. For all new compounds, evidence adequate to establish both identity and degree of purity (homogeneity) must be provided.

Identity
Melting point. All homogeneous solid products (e.g. not mixtures of isomers) should be charac­terized by melting or decomposition points. The colors and morphologies of the products should also be noted.
Specific rotations. Specific rotations based on the equation [α]tD = (100 α) / (l c) should be reported as unitless numbers as in the following example: [α]20D = -25.4 (1.93, CHCl3), where / g mL-1 is concentration and l / dm is path length. The units of the specific rotation, (deg mL) / (g dm), are implicit and are not included with the reported value.
Spectra/Spectral Data. Important IR adsorptions should be given.
For all new diamagnetic substances, NMR data should be reported (1H, 13C, and relevant heteronuclei). 1H NMR chemical shifts should be given with two digits after the decimal point. Include the number of protons represented by the signal, signal multiplicity, and coupling constants as needed (J italicized, reported with up to one digit after the decimal). The number of bonds through which the coupling is operative, xJ, may be specified by the author if known with a high degree of certainty. 13C NMR signal shifts should be rounded to the nearest 0.01 ppm unless greater precision is needed to distinguish closely spaced signals. Field strength should be noted for each spectrum, not as a comment in the general experimental section. Hydrogen multiplicity (C, CH, CH2, CH3) information obtained from routine DEPT spectra should be included. If detailed signal assignments are made, the type of NOESY or COSY methods used to establish atom connectivity and spatial relationships should be identified in the Supporting Information. Copies of spectra should also be included where structure assignments of complex molecules depend heavily on NMR interpretation. Numbering system used for assignments of signals should be given in the Supporting Information with corresponding general structural formula of named derivative.
HPLC/LCMS can be substituted for biochemistry papers where the main focus is not on compound synthesis.

HRMS/elemental analysis. To support the molecular formula assignment, HRMS data accurate within 5 ppm, or combustion elemental analysis [carbon and hydrogen (and nitrogen, if present)] data accurate within 0.5 %, should be reported for new compounds. HRMS data should be given in format as is usually given for combustion analysis: calculated mass for given formula following with observed mass: (+)ESI-HRMS m/z: [molecular formula + H]+ calculated mass, observed mass. Example: (+)ESI-HRMS m/z: calculated for [C13H8BrCl2N + H+] 327.92899, observed 327.92792.

NOTE: in certain cases, a crystal structure may be an acceptable substitute for HRMS/elemental analysis.

Biomacromolecules. The structures of biomacromolecules may be established by providing evidence about sequence and mass. Sequences may be inferred from the experimental order of amino acid, saccharide, or nucleotide coupling, from known sequences of templates in enzyme-mediated syntheses, or through standard sequencing techniques. Typically, a sequence will be accompanied by MS data that establish the molecular weight.

Example: Product was isolated upon column chromatography [dry flash (SiO2, eluent EA, EA/MeOH gradient 95/5 → 9/1, EA/MeOH/NH3 gradient 18/0.5/0.5 → 9/1/1, and flash chromatography (Biotage SP1, RP column, eluent MeOH/H2O gradient 75/25 → 95/5, N-H column, eluent EA/Hex gradient 6/3 → EA). was obtained after flash column chromatography (Biotage SP NH column, eluent hexane/EA 4:6 → 2:6). Yield 968.4 mg (95 %). Colorless foam softens at 96-101 °C. [α]20= +0,163 (c = 2.0×10-3 g/mL, CH2Cl2). IR (ATR): 3376w, 2949m, 2868w, 2802w, 1731s, 1611w, 1581s, 1528m, 1452m, 1374s, 1331w, 1246s, 1171m, 1063w, 1023m, 965w, 940w, 881w, 850w, 807w, cm-1. 1H NMR (500 MHz, CDCl3, δ): 8.46 (d, 1H, J = 5.4, H-2’), 7.89 (s, 1H,  J = 2.0, H-8’), 7.71 (d, 1H, J = 8.9, H-5’), 7.30 (dd, 1H, J1 = 8.8, J2 = 2.1, H-6’), 6.33 (d, 1H, J = 5.4, H-3’), 6.07 (s, HN-Boc, exchangeable with D2O), 5.06 (s, 1H, H-12),
4.92-4.88 (m, 1H, H-7), 4.42 (bs, H-3), 3.45 (s,CH3-N), 3.33 (bs, H-9’), 3.05-2.95 (m, 2H, H-11’), 2.70-2.43 (m, 2H, H-24) and HN, exchangeable with D2O), 2.07 (s, CH3COO), 2.04 (s, CH3COO), 1.42 (s, 9H, (CH3)3C-N(Boc)), 0.88 (s, 3H, CH3-10), 0.79 (d, 3H, J = 6.6, CH3-20), 0.68 (s, 3H, CH3-13). 13C NMR (125 MHz, CDCl3, δ): 170.34, 170.27, 151.80, 149.92, 148.87, 134.77, 128.36, 125.11, 121.43, 117.29, 99.98, 75.41, 70.82, 50.43, 49.66, 47.60, 47.33, 44.97, 43.30, 41.83, 41.48, 37.65, 36.35, 35.44, 34.89, 34.19, 33.23, 31.24, 28.79, 28.35, 27.25, 26.45, 25.45, 22.74, 22.63, 21.57, 21.31, 17.85, 12.15. (+)ESI-HRMS (m/z): calculated for [C45H67ClN4O6 + H]+ 795.48219, observed 795.48185. Combustion analysis for C45H67ClN4O6: Calculated. C 67.94, H 8.49, N 7.04; found C 67.72, H 8.63, N 6.75. HPLC purity: method A: RT 1.994, area 99.12 %; method C: RT 9.936, area 98.20 %.

Purity
Evidence for documenting compound purity should include one or more of the following:
(1) Well-resolved high field 1D 1H NMR spectrum showing at most only trace peaks not attributable to the assigned structure and a standard 1D proton-decoupled 13C NMR spectrum. Copies of the spectra should be included as figures in the Supporting Information.
(2) Quantitative gas chromatographic analytical data for distilled or vacuum-transferred samples, or quantitative HPLC analytical data for materials isolated by column chromatography or separation from a solid support. HPLC analyses should be performed in two diverse systems. The stationary phase, solvents (HPLC), detector type, and percentage of total chromatogram integration should be reported; a copy of the chromatograms may be included as a figure in the Supporting Information.
(3) Electrophoretic analytical data obtained under conditions that permit observing impurities present at the 5 % level.
HRMS data may be used to support a molecular formula assignment but cannot be used as a criterion of purity.

4. Biological Data
Quantitative biological data are required for all tested compounds. Biological test methods must be referenced or described in sufficient detail to permit the experiments to be repeated by others. Detailed descriptions of biological methods should be placed in the experimental section. Standard compounds or established drugs should be tested in the same system for comparison. Data may be presented as numerical expressions or in graphical form; biological data for extensive series of compounds should be presented in tabular form. Tables consisting primarily of negative data will not usually be accepted; however, for purposes of documentation they may be submitted as supporting information.
Active compounds obtained from combinatorial syntheses should be resynthesized and retested to verify that the biology conforms to the initial observation.
Statistical limits (statistical significance) for the biological data are usually required. If statistical limits cannot be provided, the number of determinations and some indication of the variability and reliability of the results should be given. Referen­ces to statistical methods of calculation should be included. Doses and concentrations should be expressed as molar quanti­ties (e.g., mol/kg, μmol/kg, M, mM). The routes of administration of test compounds and vehicles used should be indica­ted, and any salt forms used (hydrochlorides, sulfates, etc.) should be noted. The physical state of the compound dosed (crystalline, amorphous; solution, suspension) and the formulation for dosing (micronized, jet-milled, nanoparticles) should be indicated. For those compounds found to be inactive, the highest concentration (in vitro) or dose level (in vivo) tested should be indicated.

 

The RESULTS AND DISCUSSION should include concisely presented results and there significance discussed and compared to relevant literature data. The results and discussion may be combined or kept separate.

The inclusion of a CONCLUSION section, which briefly summarizes the principal conclusions, is highly recommended.

NOMENCLATURE is optional but, if the authors wish, a list of employed symbols may be included.

REFERENCES should be numbered sequentially as they appear in the text. Please note that any reference numbers appearing in the Illustrations and/or Tables and corresponding captions must follow the numbering sequence of the paragraph in which they appear for the first time. When cited, the reference number should be superscripted in Font 12, following any punctuation mark. In the reference list, they should be in normal position followed by a full stop. Reference entry must not be formatted using Carriage returns (enter key) or multiple space key. The formatting of references to published work should follow the Journal’s style as follows:

Journals*:

A. B. Surname1, C. D. Surname2, J. Serb. Chem. Soc. Vol (Year) first page Number

Books:

A. B. Surname1, C. D. Surname2, Name of Book, Publisher, City,  Country, Year, p. 100

Compilations:

A. B. Surname1, C. D. Surname2, Title of Chapter, in Name of Compilation, A. B. Editor1, C. D. Editor2, Ed(s)., Publisher, City, Country, Year, p. 100

Proceedings:

A. B. Surname1, C. D. Surname2, Title of the Proceeding, in Proceeding of Name of the Conference or Symposium, (Year), Place of the Conference, Country, Title of the Proceeding Book, Publisher, City, Year, p. or Abstract No. 100

Patents:

A. B. Inventor1, C. D. Inventor2, (Holder), Country Code and patent number (registration year)

Chemical Abstracts:

A. B. Surname1, C. D. Surname2, Chem. Abstr. CA 234 567a
For non-readily available literature, the Chemical Abstracts reference should be given in square brackets: [C.A. 139/2003 357348t] after the reference

Standards:

EN ISO 250: Name of the Standard (Year)

Websites:

Title of the website, URL in full, (date accessed)

*  When citing Journals, the International Library Journal abbreviation is required. Please consult, e.g. http://www.library.ubc.ca/scieng/coden.html

Only the last entry in the reference list should end with a full stop.

We suggest you to use Mendeley, a free reference manager (www.mendeley.com) and J. Serb. Chem. Soc. Citation Style (http://csl.mendeley.com/styles/453673811/j-serb-chem-soc). 

Formatted list of references for works cited in each submission must be additionally uploaded (Online Submissions Step 3). 

The names of all authors should be given in the list of references; the abbreviation et al. may only be used in the text. The original journal title is to be retained in the case of publications published in any language other than English (please denote the language in parenthesis after the reference). Titles of publications in non-Latin alphabets should be transliterated. Russian references are to be transliterated using the following transcriptions:

ж→zh,  ҳ→kh,  ц→ts,  ч→ch,  ш→sh,  щ→shch,  ы→y,  ю→yu,  я→ya,  э→e,  й→i,  ь→’.

Supplementary material
Authors are encouraged to presentthe information and results non-essential to the understanding of their paper as SUPPLEMENTARY MATERIAL (can be uploaded in Step 4 of Online Submission). This materialmay include as a rule, but is not limited to, the presentation of analytical and spectral data demonstrating the identity and purity of synthesized compounds, tables containing raw data on which calculations were based, series of figures where one example would remain in the main text, etc. The Editorial Board retain the right to assign such information and results to the Supplementary material when deemed fit. Supplementary material does not appear in printed form but can be downloaded from the web site of the JSCS.


Mathematical and chemical equations should be given in separate lines and must be numbered, Arabic numbers, consecutively in parenthesis at the end of the line. All equations should be embedded in the text except when they contain graphical elements (tables, figures, schemes and formulae). Complex equations (fractions, integrals, matrix…) should be prepared with the aid of the Microsoft Equation 3.0 (or higher) or MathType (Do not use them to create simple equations and labels). Using the Insert -> Equation option, integrated in MS Office 2010 and MS Office 2013, as well as insertion of equation objects within paragraph text IS NOT ALLOWED.

Deposition of crystallographic data
Prior to submission, the crystallographic data included in a manuscript presenting such data should be deposited at the appropriate database. Crystallographic data associated with organic and metal-organic structures should be deposited at the Cambridge Crystallographic Data Centre (CCDC) by e-mail to deposit@ccdc.cam.ac.uk.
Crystallographic data associated with inorganic structures should be deposited with the Fachinformationszentrum Karlsruhe (FIZ) by e-mail to crysdata@fiz-karlsruhe.de. A deposition number will then be provided, which should be added to the reference section of the manuscript.

MANUSCRIPT REVISION

After evaluation of the manuscript by reviewers, the corresponding author will receive notification and reviewers’ reports by an email. The corresponding author should upload the revised manuscript according to the reviewers' suggestions and detailed answers to the reviewers’ comments within 60 days at the longest. If no communication from the corresponding author is received by this time period, the Manuscript will be considered as withdrawn. To submit the revised manuscript, please go to JSCS OnLine article processing service http://www.shd.org.rs/JSCS/ and login as Author (with your registered username and password). Please upload:

1. The corrected manuscript with clearly marked revised sections (as a .doc or .docx file in the "REVIEW" Section (in the second heading on the top of the page) – Editor Decision - Upload author version option);
 
2. Detailed answers to all of the reviewers’ comments as a .doc or .pdf file in "ADD SUPPLEMENTARY FILE" option under "SUMMARY" Section (in the second heading on the top of the page) of your submission (in the Title field please write "Response to Reviewers") 
 
3. Corrected Figure(s) (also as SUPPLEMENTARY FILES - see the above figure; please give titles as Corrected Fig.xxx, Type: Illistration(s)....).

Please note that all files supplied in revision have to be available to reviewers - hence, please mark "Present file to reviewers" during the upload of supplementary files.

If the metadata are changed in the meantime it is obligatory to insert new metadata (please correct it in "SUMMARY"section, EDIT METADATA option, if necessary).

Upon completion, send the Notify Editor email to the Editor ("REVIEW"section - Editor Decision option).

*********************************************************************************************************************** 

ARTWORK INSTRUCTIONS

JSCS accepts only TIFF or EPS formats, as well as JPEG format (only for colour and greyscale photographs) for electronic artwork and graphic files. MS files (Word, PowerPoint, Excel, Visio) NOT acceptable. Generally, scanned instrument data sheets should be avoided. Authors are responsible for the quality of their submitted artwork. Every single Figure or Scheme, as well as any part of the Figure (A, B, C…) should be prepared according to following instructions (every part of the figure, A, B, C…, must be submitted as an independent single graphic file):

TIFF
Virtually all common artwork and graphic creation software is capable of saving files in TIFF format. This 'option' can normally be found under 'the 'Save As...' or 'Export...' commands in the 'File' menu.
TIFF (Tagged Image File Format) is the recommended file format for bitmap, greyscale and colour images.

  • Colour images should be in the RGB mode
  • When supplying TIFF files, please ensure that the files are supplied at the correct resolution:
  1. Line artwork: minimum of 1000 dpi
  2. RGB image: minimum of 300 dpi
  3. Greyscale image: minimum of 300 dpi
  4. Combination artwork (line/greyscale/RGB): minimum of 500 dpi
  • Images should be tightly cropped, without frame and any caption.
  • If applicable please re-label artwork with a font supported by JSCS (Arial, Helvetica, Times, Symbol) and ensure it is of an appropriate font size.
  • Save an image in TIFF format with LZW compression applied.
  • It is recommended to remove Alpha channels before submitting TIFF files.
  • It is recommended to flatten layers before submitting TIFF files.

Please be sure that quality of an image cannot be increased by changing the resolution from lower to higher, but only by rescanning or exporting the image with higher resolution, which can be set in usual "settings" facilities.

EPS
Virtually all common artwork creation software, such as Canvas, ChemDraw, CorelDraw, SigmaPlot, Origin Lab…, are capable of saving files in EPS format. This 'option' can normally be found under the 'Save As...' or 'Export...' commands in the 'File' menu.
For vector graphics, EPS (Encapsulated PostScript) files are the preferred format as long as they are provided in accordance with the following conditions:

  • when they contain bitmap images, the bitmaps should be of good resolution (see instructions for TIFF files)
  • when colour is involved, it should be encoded as RGB
  • an 8-bit preview/header at a resolution of 72 dpi should always be included
  • embed fonts should always included and only the following fonts should be used in artwork: Arial, Helvetica, Times, Symbol
  • the vertical space between the parts of an illustration should be limited to the bare necessity for visual clarity
  • no data should be present outside the actual illustration area
  • line weights should range from 0.35 pt to 1.5 pt
  • when using layers, they should be reduced to one layer before saving the image (Flatten Artwork)

JPEG
Virtually all common artwork and graphic creation software is capable of saving files in JPEG format. This 'option' can normally be found under 'the 'Save As...' or 'Export...' commands in the 'File' menu.
JPEG (Joint Photographic Experts Group) is the acceptable file format only for colour and greyscale photographs. JPEG can be created with respect to photo quality (low, medium, high; from 1 to 10), ensuring file sizes are kept to a minimum to aid easy file transfer. Images should have a minimum resolution of 300 dpi. Image width: minimum 3.0 cm; maximum 12.0 cm.

Please be sure that quality of an image cannot be increased by changing the resolution from lower to higher, but only by rescanning or exporting the image with higher resolution, which can be set in usual "settings" facilities.

SIZING OF ARTWORK
JSCS aspires to have a uniform look for all artwork contained in a single article. Hence, it is important to be aware of the style of the journal.
Figures should be submitted in black and white or, if required, colour (charged). If coloured figures or photographs are required, this must be stated in the cover letter and arrangements made for payment through the office of the Serbian Chemical Society.
As a general rule, the lettering on an artwork should have a finished, printed size of 11 pt for normal text and no smaller than 7 pt for subscript and superscript characters. Smaller lettering will yield a text that is barely legible. This is a rule-of-thumb rather than a strict rule. There are instances where other factors in the artwork, (for example, tints and shadings) dictate a finished size of perhaps 10 pt. Lines should be of at least 1 pt thickness.
When deciding on the size of a line art graphic, in addition to the lettering, there are several other factors to address. These all have a bearing on the reproducibility/readability of the final artwork. Tints and shadings have to be printable at the finished size. All relevant detail in the illustration, the graph symbols (squares, triangles, circles, etc.) and a key to the diagram (to explain the explanation of the graph symbols used) must be discernible.
The sizing of halftones (photographs, micrographs,...) normally causes more problems than line art. It is sometimes difficult to know what an author is trying to emphasize on a photograph, so you can help us by identifying the important parts of the image, perhaps by highlighting the relevant areas on a photocopy. The best advice that can be given to graphics suppliers is not to over-reduce halftones. Attention should also be paid to magnification factors or scale bars on the artwork and they should be compared with the details inside. If a set of artwork contains more than one halftone, again please ensure that there is consistency in size between similar diagrams.

General sizing of illustrations which can be used for the Journal of the Serbian Chemical Society:
Minimum fig. size: 30 mm width
Small fig. size - 60 mm width
Large fig. size - 90 mm width
Maximum fig. size - 120 mm width

Pixel requirements (width) per print size and resolution for bitmap images:

 

Image width

A

B

C

Minimal size

      30 mm

         354

         591

        1181

Small size

      60 mm

         709

        1181

        2362

Large size   

      90 mm

        1063

        1772

        3543

Maximal size

     120 mm

        1417

        2362

        4724

A: 300 dpi >   RGB or Greyscale image
B: 500 dpi >    Combination artwork (line/greyscale/RGB)
C: 1000 dpi> Line artwork

The designation of physical quantities and graphs formatting
The designation of physical quantities on figures must be in italic, whereas the units are in upright letters. They should be in Times New Roman font. In graphs a slash should be used to separate the designation of a physical quantity from the unit (example: p / kPa, j / mA cm-1T0 / K, t / h, ln (j / mA cm-2)…). Designations such as: p (kPa), t [min]…, are not acceptable. However, if the full name of a physical quantity is unavoiable, it should be given in upright letters and separated from the unit by a comma (example: Pressure, kPa, Temperature, K…). Please do not use the axes of graphs for additional explanations; these should be mentioned in the figure captions and/or the manuscript (example: “pressure at the inlet of the system, kPa” should be avoided). The axis name should follow the direction of the axis (the name of y‑axis should be rotated by 90°). Top and right axes should be avoided in diagrams, unless they are absolutely necessary. Decimal numbers must have decimal points and not commas in the axis labels in graphical presentations of results. Thousands are separated, if at all, by a comma and not a point.

 

   

 

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word or RTF document file format.

    Illustrations is in TIF or EPS format, JPG format is acceptable for colour and greyscale photos, only. Must be additionally uploaded (Online Submissions step 4) as a separate files or one archived (.zip, .rar or .arj) file. 

  3. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.

    DOWNLOAD JSCS TEMPLATE
    (Right click - save as... option) 

    • Name of author(s) denoted as the corresponding author(s), together with their e-mail address, full postal address and telephone/fax numbers are given (incuding Step 3. Entering the Submission's Metadata);
    • Full names (First and last) of all authors are provided;
    • The names and addresses of potential Referees are provided;
    • The files are in the correct format: manuscript in MS Word; illustration in TIFF or EPS (JPG format is acceptable for colour and greyscale photos only);
    • Keywords and Running title are provided;
    • The references are in the correct format (see Instructions for Authors for details);
    • All references mentioned in the Reference list are cited in the text, and vice versa;
    • The recommended naming conventions (see Instruction for Authors) have been used;
    • The manuscript has been ‘spell checked’;
    • All tables (including captions and footnotes) are present;
    • All artwork is numbered according to its sequence in the text;
    • All illustrations are provided as separate graphic files. It is recommended to remove Alpha channels and to flatten layers before submitting TIFF files;
    • The graphics are of high-resolution (preferred formats are either TIFF or EPS; ensure all necessary files have been uploaded);
    • The color images are provided in the RGB colorspace;
    • The physical dimensions of the artwork match the required dimensions (See Artwork Instructions);
    • The lettering used in the artwork does not vary greatly in size (See Artwork Instructions);
    • Permission has been obtained for use of copyrighted material from other sources (including the Web);
    • All the rights are cleared both for print and electronic publication;
    • The required warranty is included with the cover letter
  4. Conflict-of-Interest Statement*: Public trust in the peer review process and the credibility of published articles depend in part on how well a conflict of interest is handled during writing, peer review, and editorial decision making. A conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for a conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

    Informed Consent Statement*: Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.  Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.  The requirement for informed consent should be included in the journal's instructions for authors. When informed consent has been obtained it should be indicated in the published article.

    Human and Animal Rights Statement*: When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.       

    * International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals") -- February 2006

  5. I accept, if provisionally accepted, unedited version of my manuscript to be published in OnLine First section of the JSCS website.

    For OnLine First publication, please note that the Manuscript Title, authors’ names and affiliations, as well as the Abstract, will appear in the article listing in the form and in the order entered in the author details on Step 3. You are obliged to correct these data, if they require some changes, while the manuscript is in reviewing and editing procedure by accessing the „EDIT METADATA“ Section of your submission. Once the author copyediting procedure is finished, these data in the listing will appear as given in the manuscript.

 

Copyright Notice

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors grant to the Publisher the following rights to the manuscript, including any supplemental material, and any parts, extracts or elements thereof:

  • the right to reproduce and distribute the Manuscript in printed form, including print-on-demand;
  • the right to produce prepublications, reprints, and special editions of the Manuscript;
  • the right to translate the Manuscript into other languages;
  • the right to reproduce the Manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these reproductions;
  • the right to reproduce and distribute the Manuscript electronically or optically on any and all data carriers or storage media – especially in machine readable/digitalized form on data carriers such as hard drive, CD-Rom, DVD, Blu-ray Disc (BD), Mini-Disk, data tape – and the right to reproduce and distribute the Article via these data carriers; 
  • the right to store the Manuscript in databases, including online databases, and the right of transmission of the Manuscript in all technical systems and modes;
  • the right to make the Manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the internet, other online services, or via internal or external networks.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

 

Author Fees

This journal charges the following author fees.

Figures in colour: 30.00 (EUR)

Figures in colour: 30 EUR (equivalent in RSD) per printed pagecontaining coloured figure (no charge for Online version). If the paper contains color figures, together with the receipt of the request for proofreading, the authors will be asked whether they want the figures to be printed in color. 

Payment through the Serbian Chemical Society Office. 

Journal can not waive "Figures in colour" fee